A New Artificial Intelligence Tool for Cancer Diagnosis
A new AI model is capable of diagnosing multiple types of cancer, predicting patient survival, and identifying tumor molecular profiles.
Read More
Search Results for: lung cancer
FDA Approves Cancer Biomarker Test with Two Companion Diagnostics for Targeted Therapy
The FDA approved Illumina’s oncology comprehensive test as an IVD tool, along with its first two CDx indications for cancer patients.
Read More
DELFI Diagnostics Taps New CFO
Summary: DELFI Diagnostics appointed Thomas Russo as its new CFO to support the company’s...
Read More
AI-Powered Digital Pathology Platform Aids Lung Cancer Diagnosis
A new AI-driven digital pathology platform enables fully automated, rapid, and accurate analysis of lung cancer tissue.
Read More
Open Comment Period to Revise Molecular Testing Guidelines in Lung Cancer Treatment Announced
Several diagnostic associations announced the open comment period for the revised 2018 guideline on molecular testing for lung cancer.
Read More